Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Virpax Pharmaceuticals, Inc. (VRPX)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/16/2023 |
4/A
| Shah Vinay (CFO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 100,000 options to buy
@ $0.99, valued at
$99k
|
|
| 02/07/2023 |
4/A
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 125,000 options to buy
@ $0.867, valued at
$108.4k
|
|
| 02/25/2022 |
4/A
| Gudin Jeffrey (Chief Medical Officer) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,676 options to buy
@ $2.13, valued at
$129.2k
|
|
| 02/25/2022 |
4/A
| Mack Anthony P. (CEO) has filed a Form 4 on Virpax Pharmaceuticals, Inc.|
Txns:
| Granted 60,676 options to buy
@ $2.13, valued at
$129.2k
|
|
| 02/25/2022 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities: [Amend] |
|
|